Boulevad Pharmaceutical Center is categorized under in Worcester, MA and active since 1986.
Boulevad Pharmaceutical Center was established in 1986, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Joe Rossetti, Owner at the company’s single location by writing to 149 Shrewsbury St, Worcester, Massachusetts MA 01604 or by phoning (508) 754-1791. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Boulevad Pharmaceutical Center |
| Contact Person: | Joe Rossetti, Owner |
| Address: | 149 Shrewsbury St, Worcester, Massachusetts 01604 |
| Phone Number: | (508) 754-1791 |
| Website Address: | boulevardcompounding.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1986 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
Boulevad Pharmaceutical Center was started in 1986 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Joe Rossetti, Owner for inquiries that concern Boulevad Pharmaceutical Center by calling the company number (508) 754-1791, as your correspondence is most welcome. Additionally, the physical location of the single location of Boulevad Pharmaceutical Center can be found at the coordinates 42.264771,-71.787602 as well as the street address 149 Shrewsbury St in Worcester, Massachusetts 01604.
For its online presence, you may visit Boulevad Pharmaceutical Center’s website at boulevardcompounding.com and engage with its social media outlets through on Twitter and on Facebook.